Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis-论文-万方医学网

Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis

导出原文传递

翻译打印收藏纠错

作者： Jiang, Yawen ^[1] ; Liu, Jia ^[2] ; Chen, Xin ^[3] ; Yang, Wenying ^[4] ; Jia, Weiping ; Wu, Jing

作者单位： Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen, Guangdong, Peoples R China ^[1] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China ^[2] China Japan Friendship Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China ^[3] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai, Peoples R ^[4]

关键词 Cardiovascular Glucagon-like peptide&160 1 HbA(1c)Network meta-analysis Type&2 diabetes mellitus

发布时间 2022-09-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除